Citations (164)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Andrew G. Muntean, Yubin Ge, Jeffrey W. Taub & John D. Crispino. (2006) Transcription factor GATA-1 and Down syndrome leukemogenesis. Leukemia & Lymphoma 47:6, pages 986-997.
Read now
Read now
Anshu Awasthi, Reena Das, Neelam Varma, Jasmina Ahluwalia, Anju Gupta, R. K. Marwaha & Gurjeewan Garewal. (2005) HEMATOLOGICAL DISORDERS IN DOWN SYNDROME: Ten-Year Experience at a Tertiary Care Centre in North India. Pediatric Hematology and Oncology 22:6, pages 507-512.
Read now
Read now
Ritsuko Shimizu, Takashi Kuroha, Osamu Ohneda, Xiaoqing Pan, Kinuko Ohneda, Satoru Takahashi, Sjaak Philipsen & Masayuki Yamamoto. (2004) Leukemogenesis Caused by Incapacitated GATA-1 Function. Molecular and Cellular Biology 24:24, pages 10814-10825.
Read now
Read now
Alvin Zipursky, Toby Rose, Martin Skidmore, Paul Thorner & John Doyle. (1996) Hydrops Fetalis and Neonatal Leukemia in Down Syndrome. Pediatric Hematology and Oncology 13:1, pages 81-87.
Read now
Read now
Daniel Satgé, Grete Krag Jacobsen, Françoise Cessot, Fernand Raffi & Michel Vekemans. (1996) A Fetus with Down Syndrome and Intratubular Germ Cell Neoplasia. Pediatric Pathology & Laboratory Medicine 16:1, pages 107-112.
Read now
Read now
Alvin Zipursky, Hilary Christensen & Etienne De Harven. (1995) Ultrastructural Studies of the Megakaryoblastic Leukemias of Down Syndrome. Leukemia & Lymphoma 18:3-4, pages 341-347.
Read now
Read now
J. J. Doyle, P. Thorner, A. Poon, K. Tanswell, S. Kamel Reid & A. Zipursky. (1995) Transient Leukemia Followed by Megakaryoblastic Leukemia in a Child with Mosaic Down Syndrome. Leukemia & Lymphoma 17:3-4, pages 345-350.
Read now
Read now
Articles from other publishers (157)
Nikhil Raghuram, Daisuke Hasegawa, Kentaro Nakashima, Syaza Rahman, Evangelia Antoniou, Torjus Skajaa, Pietro Merli, Anupam Verma, Karen R. Rabin, Catherine Aftandilian, Rishi S. Kotecha, Daniel Cheuk, Kirsi Jahnukainen, Alexandra Kolenova, Walentyna Balwierz, Alice Norton, Maureen O’Brien, Sonia Cellot, Ashley Chopek, Nira Arad-Cohen, Bianca Goemans, Marta Rojas-Vasquez, Hany Ariffin, Jack Bartram, E. Anders Kolb, Franco Locatelli, Jan-Henning Klusmann, Henrik Hasle, Bryan McGuire, Afia Hasnain, Lillian Sung & Johann Hitzler. (2023) Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome. Blood Advances 7:21, pages 6532-6539.
Crossref
Crossref
David A. Alagpulinsa, Mabel P. Toribio, Iad Alhallak & Robert J. Shmookler Reis. (2022) Advances in understanding the molecular basis of clonal hematopoiesis. Trends in Molecular Medicine 28:5, pages 360-377.
Crossref
Crossref
L. Alexander Liggett, Matthew D. Galbraith, Keith P. Smith, Kelly D. SullivanRoss E. GranrathBelinda Enriquez-EstradaKohl T. Kinning, Jessica R. Shaw, Angela L. Rachubinski, Joaquin M. Espinosa & James DeGregori. (2021) Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation. Blood Advances 5:7, pages 1791-1796.
Crossref
Crossref
John O. Marentette, Colin C. Anderson, Kendra M. Prutton, Erin Q. Jennings, Abhishek K. Rauniyar, James J. Galligan & James R. Roede. (2021) Trisomy 21 impairs PGE2 production in dermal fibroblasts. Prostaglandins & Other Lipid Mediators 153, pages 106524.
Crossref
Crossref
Kenichiro Watanabe. (2019) Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome. Pediatrics International 61:3, pages 222-229.
Crossref
Crossref
Kailash Chandra Mangalhara & R. N. K. Bamezai. 2019. Models, Molecules and Mechanisms in Biogerontology. Models, Molecules and Mechanisms in Biogerontology
211
239
.
Milan Škorvaga, Matúš Durdík, Pavol Košík, Eva Marková, Marek Holop, Miroslav Kubeš, Judita Puškáčová, Alexandra Kolenová & Igor Belyaev. (2018) Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia. Oncotarget 9:27, pages 19233-19244.
Crossref
Crossref
Renata Lyrio Rafael Baptista, Anna Cláudia Evangelista dos Santos, Luciana Mayumi Gutiyama, Cristiana Solza & Ilana Renault Zalcberg. (2017) Familial Myelodysplastic/Acute Leukemia Syndromes—Myeloid Neoplasms with Germline Predisposition. Frontiers in Oncology 7.
Crossref
Crossref
Satoshi Saida. (2017) Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders. Current Treatment Options in Oncology 18:7.
Crossref
Crossref
Kevin M. Bloh, Pawel A. Bialk, Anilkumar Gopalakrishnapillai, E. Anders Kolb & Eric B. Kmiec. (2017) CRISPR/Cas9-Directed Reassignment of the GATA1 Initiation Codon in K562 Cells to Recapitulate AML in Down Syndrome. Molecular Therapy - Nucleic Acids 7, pages 288-298.
Crossref
Crossref
Stylianos E. Antonarakis. (2016) Down syndrome and the complexity of genome dosage imbalance. Nature Reviews Genetics 18:3, pages 147-163.
Crossref
Crossref
Vandana Baloda, Papagudi G. Subramanian, Yajamanam Badrinath, Ashok Kumar, Pratibha S. Kadam Amare, Shripad D. Banavali, Brijesh Arora & Sumeet Gujral. (2017) Transient abnormal myelopoiesis: A case series and review of the literature. Pediatric Hematology Oncology Journal 2:1, pages 14-18.
Crossref
Crossref
Agustín Tiol-Carrillo & Patricia Enzaldo-de la Cruz. (2017) Pre-bacute lymphoblastic leukemia: case report and literature review. Revista Odontológica Mexicana 21:1, pages e54-e60.
Crossref
Crossref
Agustín Tiol-Carrillo & Patricia Enzaldo-de la Cruz. (2017) Leucemia aguda linfoblástica Pre-B. Informe de un caso y revisión de la literatura. Revista Odontológica Mexicana 21:1, pages 54-60.
Crossref
Crossref
Etsuro Ito, Kiminori Terui & Tsutomu Toki. 2017. Hematological Disorders in Children. Hematological Disorders in Children
145
170
.
IM Parra-Baltazar, SGE Quispe-Iporra, C Pinto-Dongo, Y Sullcahuamán -Allende, V Cruzate-Cabrejos & MC Castro-Mujica. (2016) Síndrome de Down mosaico y leucemia linfoblástica aguda de células B: reporte de un caso. IATREIA 29:4.
Crossref
Crossref
Satoshi Saida. (2016) Evolution of myeloid leukemia in children with Down syndrome. International Journal of Hematology 103:4, pages 365-372.
Crossref
Crossref
Tina Vetter, Andreas Borowski, Andreas Wohlmann, Nilabh Ranjan, Michael Kuepper, Susanne Badura, Oliver G. Ottmann & Karlheinz Friedrich. (2016) Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients. Leukemia Research 40, pages 38-43.
Crossref
Crossref
Alan B. Cantor. (2014) Myeloid proliferations associated with Down syndrome. Journal of Hematopathology 8:3, pages 169-176.
Crossref
Crossref
Laurence Rozen, Sophie Huybrechts, Laurence Dedeken, Catherine Heijmans, Barbara Dessars, Pierre Heimann, Frédéric Lambert, Denis F. Noubouossie, Alina Ferster & Anne Demulder. (2013) Transient leukemia in a newborn without Down syndrome: case report and review of the literature. European Journal of Pediatrics 173:12, pages 1643-1647.
Crossref
Crossref
Melissa BomberyJo-Anne Vergilio. (2014) Transient Abnormal Myelopoiesis in Neonates: GATA Get the Diagnosis. Archives of Pathology & Laboratory Medicine 138:10, pages 1302-1306.
Crossref
Crossref
John F. Bithell. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online.
Sarangarajan Ranganathan. 2014. The Pediatric and Perinatal Autopsy Manual. The Pediatric and Perinatal Autopsy Manual
262
283
.
Sergey I. Nikolaev, Marco Garieri, Federico Santoni, Emilie Falconnet, Pascale Ribaux, Michel Guipponi, Aoife Murray, Jürgen Groet, Emanuela Giarin, Giuseppe Basso, Dean Nizetic & Stylianos E. Antonarakis. (2014) Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nature Communications 5:1.
Crossref
Crossref
Timothy J. Mick. 2014. Clinical Imaging. Clinical Imaging
425
475
.
Steven W. Hwang & Andrew Jea. (2013) A Review of the Neurological and Neurosurgical Implications of Down Syndrome in Children. Clinical Pediatrics 52:9, pages 845-856.
Crossref
Crossref
Sergey I. NikolaevFederico SantoniAnne VannierEmilie FalconnetEmanuela GiarinGiuseppe BassoAlexander Hoischen, Joris A. Veltman, Jurgen Groet, Dean Nizetic & Stylianos E. Antonarakis. (2013) Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome. Blood 122:4, pages 554-561.
Crossref
Crossref
Satoshi SaidaKen-ichiro WatanabeAiko Sato-OtsuboKiminori TeruiKenichi YoshidaYusuke OkunoTsutomu TokiRuNan WangYuichi ShiraishiSatoru MiyanoItaru KatoTatsuya MorishimaHisanori FujinoKatsutsugu UmedaHidefumi HiramatsuSouichi AdachiEtsuro ItoSeishi OgawaMamoru Ito, Tatsutoshi Nakahata & Toshio Heike. (2013) Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome. Blood 121:21, pages 4377-4387.
Crossref
Crossref
Luca Lo Nigro. (2013) Biology of Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 35:4, pages 245-252.
Crossref
Crossref
Tsutomu TokiRika KanezakiEri KobayashiHiroshi KanekoMikiko SuzukiRuNan WangKiminori TeruiHirokazu KaneganeMiho MaedaMikiya EndoTatsuki MizuochiSouichi Adachi, Yasuhide Hayashi, Masayuki Yamamoto, Ritsuko ShimizuEtsuro Ito. (2013) Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome. Blood 121:16, pages 3181-3184.
Crossref
Crossref
Omer Faruk Hatipoglu, Onur Bender, Esra Gunduz & Mehmet Gunduz. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
237
248
.
David A. Sweetser & Howard J. Weinstein. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
355
373
.
Alan S. Gamis & Franklin O. Smith. (2012)
Transient myeloproliferative disorder in children with
D
own syndrome: clarity to this enigmatic disorder
. British Journal of Haematology 159:3, pages 277-287.
Crossref
Crossref
Dean Nižetić & Jürgen Groet. (2012) Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nature Reviews Cancer 12:10, pages 721-732.
Crossref
Crossref
Susanne Haemmerling, Wolfgang Behnisch, Tobias Doerks, Jan O. Korbel, Peer Bork, Ute Moog, Sabine Hentze, Ute Grasshoff, Michael Bonin, Olaf Rieß, Johannes W. G. Janssen, Anna Jauch, Claus R. Bartram, Dirk Reinhardt, Karin A. Koch, Obul R. Bandapalli & Andreas E. Kulozik. (2012)
A 15q24 microdeletion in transient myeloproliferative disease (
TMD
) and acute megakaryoblastic leukaemia (
AMKL
) implicates
PML
and
SUMO
3 in the leukaemogenesis of
TMD
/
AMKL
. British Journal of Haematology 157:2, pages 180-187.
Crossref
Crossref
Asahito Hama, Hideki Muramatsu, Hideki Makishima, Yuka Sugimoto, Hadrian Szpurka, Monika Jasek, Christine O’Keefe, Yoshiyuki Takahashi, Hirotoshi Sakaguchi, Sayoko Doisaki, Akira Shimada, Nobuhiro Watanabe, Koji Kato, Hitoshi Kiyoi, Tomoki Naoe, Seiji Kojima & Jaroslaw P. Maciejewski. (2012) Molecular lesions in childhood and adult acute megakaryoblastic leukaemia. British Journal of Haematology 156:3, pages 316-325.
Crossref
Crossref
Fran Hickey, Erin Hickey & Karen L. Summar. (2012) Medical Update for Children With Down Syndrome for the Pediatrician and Family Practitioner. Advances in Pediatrics 59:1, pages 137-157.
Crossref
Crossref
William L. Carroll & Elizabeth A. Raetz. (2012) Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia. The Journal of Pediatrics 160:1, pages 10-18.
Crossref
Crossref
Alan S. GamisTodd A. AlonzoRobert B. GerbingJoanne M. HildenApril D. SorrellMukta SharmaThomas W. LoewRobert J. ArceciDorothy BarnardJohn DoyleGita MasseyJohn Perentesis, Yaddanapudi Ravindranath, Jeffrey Taub & Franklin O. Smith. (2011) Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood 118:26, pages 6752-6759.
Crossref
Crossref
Yoshihiko Maeda, Koichi Yoshikawa, Koji Kajiwara, Makoto Ideguchi, Takayuki Amano, Makoto Saka, Sadahiro Nomura, Masami Fujii & Michiyasu Suzuki. (2011) Intracranial yolk sac tumor in a patient with Down syndrome. Journal of Neurosurgery: Pediatrics 7:6, pages 604-608.
Crossref
Crossref
Annan Yang & Roger H. Reeves. (2011) Increased Survival following Tumorigenesis in Ts65Dn Mice That Model Down Syndrome. Cancer Research 71:10, pages 3573-3581.
Crossref
Crossref
Geeta Gathwala, Poonam Dalal, Jagjit Singh Dalal & Ojasvini Choudhry. (2011) Transient aplastic anemia in Down’s syndrome – A rare association. European Journal of Medical Genetics 54:3, pages 341-342.
Crossref
Crossref
Robert B. Lorsbach. 2011. Diagnostic Pediatric Hematopathology. Diagnostic Pediatric Hematopathology
272
309
.
Robert E. Hutchison & Katherine I. Schexneider. 2011. Henry's Clinical Diagnosis and Management by Laboratory Methods. Henry's Clinical Diagnosis and Management by Laboratory Methods
601
655
.
Julie A. Ross, Kimberly J. Johnson, Logan G. Spector & John H. Kersey. 2011. Childhood Leukemia. Childhood Leukemia
3
26
.
Adam J. de Smith, Anne L. Trewick & Alexandra I. F. Blakemore. (2010) Implications of copy number variation in people with chromosomal abnormalities: potential for greater variation in copy number state may contribute to variability of phenotype. The HUGO Journal 4:1-4, pages 1-9.
Crossref
Crossref
Rika KanezakiTsutomu TokiKiminori TeruiGang XuRuNan WangAkira ShimadaAsahito HamaHirokazu KaneganeKiyoshi KawakamiMikiya EndoDaisuke HasegawaKazuhiro KogawaSouichi AdachiYasuhiko IkedaShotaro IwamotoTakashi Taga, Yoshiyuki Kosaka, Seiji KojimaYasuhide HayashiEtsuro Ito. (2010) Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood 116:22, pages 4631-4638.
Crossref
Crossref
Ryan Mattison, Sarah Larson & Wendy Stock. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies
43
67
.
David K. H. Webb. 2010. Pediatric Hematology and Oncology. Pediatric Hematology and Oncology
95
108
.
Julie Tandonnet, Jacqueline Clavel, André Baruchel, Fabienne Nacka & Yves Pérel. (2010) Myeloid leukaemia in children with down syndrome: Report of the registry‐based French experience between 1990 and 2003. Pediatric Blood & Cancer 54:7, pages 927-933.
Crossref
Crossref
Catherine Vendola, Mark Canfield, Stephen P. Daiger, Michael Gambello, S. Shahrukh Hashmi, Terri King, Sarah J. Noblin, D. Kim Waller & Jacqueline T. Hecht. (2010) Survival of Texas infants born with trisomies 21, 18, and 13. American Journal of Medical Genetics Part A 152A:2, pages 360-366.
Crossref
Crossref
Ahitagni Biswas, Tarun Puri, Shikha Goyal, Sushil Kumar, Arundhati Sharma, Preeti Paliwal, Vaishali Suri, Ayushi Jain, Pramod Kumar Julka & Goura Kishor Rath. (2010) Spinal Myxopapillary Ependymoma With Down Syndrome: Exploring an Unusual Association. Journal of Pediatric Hematology/Oncology 32:1, pages e38-e41.
Crossref
Crossref
Takashi Moriguchi, Mikiko Suzuki, James Douglas Engel & Masayuki Yamamoto. 2010. Hematopoietic Stem Cell Biology. Hematopoietic Stem Cell Biology
117
142
.
Anindita Roy, Irene Roberts, Alice Norton & Paresh Vyas. (2009) Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. British Journal of Haematology 147:1, pages 3-12.
Crossref
Crossref
Lisa J. RussellMelania CapassoInga VaterTakashi AkasakaOlivier A. BernardMaria Jose CalasanzThiruppavaii ChandrasekaranElise ChapiroStephan GeskMike GriffithsDavid S. GutteryClaudia HaferlachLana HarderOlaf HeidenreichJulie IrvingLyndal Kearney, Florence Nguyen-KhacLee MachadoLynne MintoAneela MajidAnthony V. MoormanHeather MorrisonVikki RandJonathan C. Strefford, Claire SchwabHolger TönniesMartin J. S. DyerReiner SiebertChristine J. Harrison. (2009) Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 114:13, pages 2688-2698.
Crossref
Crossref
Satu Kyttälä, Ivonne Habermann, Takashi Minami, Gerhard Ehninger & Alexander Kiani. (2009) Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytes. British Journal of Haematology 144:3, pages 395-408.
Crossref
Crossref
Seymour Levine, Arthur Saltzman, Efrat Levy & Stephen D. Ginsberg. (2009) Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease. Experimental and Molecular Pathology 86:1, pages 18-22.
Crossref
Crossref
Lyndal KearneyDavid Gonzalez De CastroJenny YeungJulia ProcterSharon W. HorsleyMinenori Eguchi-IshimaeCaroline M. BatemanKristina AndersonTracy ChaplinBryan D. YoungChristine J. Harrison, Helena Kempski, Chi Wai E. SoAnthony M. FordMel Greaves. (2009) Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood 113:3, pages 646-648.
Crossref
Crossref
Jennifer J. Clark, Jason N. Berman & A. Thomas Look. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
331
402
.
Smita Bhatia & Leslie L. Robison. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
1
25
.
Niketa Shah, Ali Al‐Ahmari, Arwa Al‐Yamani, Lee Dupuis, Derek Stephens & Johann Hitzler. (2008) Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with down syndrome. Pediatric Blood & Cancer 52:1, pages 14-19.
Crossref
Crossref
Jung Sook HaWon Mok LeeJi Hye KimNam Hee RyooDong Suk JeonJae Ryong KimHeung Sik KimByung Kyu Choi. (2008)
GATA1
Mutation in Transient Myeloproliferative Disorder of Down Syndrome
. The Korean Journal of Hematology 43:1, pages 43.
Crossref
Crossref
In-Suk KimEun Sil ParkJae Young LimChang-Seok KiHyun Sook Chi. (2008) A Novel Mutation in the GATA1 Gene Associated with Acute Megakaryoblastic Leukemia in a Korean Down Syndrome Patient. Journal of Korean Medical Science 23:6, pages 1105.
Crossref
Crossref
Jeannie Visootsak & Stephanie L. Sherman. 2008.
61
102
.
Johann K. Hitzler. (2007) Acute megakaryoblastic leukemia in Down syndrome. Pediatric Blood & Cancer 49:S7, pages 1066-1069.
Crossref
Crossref
Sharon R. PineQianxu GuoChanghong YinSomasundaram JayaboseCharlotte M. Druschel & Claudio Sandoval. (2007) Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood 110:6, pages 2128-2131.
Crossref
Crossref
Somasundaram Jayabose, Oya Levendoglu-Tugal, Mehmet F. Ozkaynak, Sharon Pine & Claudio Sandoval. (2007) A Case of Relapsed Down Syndrome–Associated Acute Megakaryoblastic Leukemia Cured with Non-Myeloablative Chemotherapy. Clinical Leukemia 1:5, pages 309-312.
Crossref
Crossref
F. Tyrer, L. K. Smith & C. W. McGrother. (2007) Mortality in adults with moderate to profound intellectual disability: a population-based study. Journal of Intellectual Disability Research 51:7, pages 520-527.
Crossref
Crossref
Branda Kruger. (2007) Transient Myeloproliferative Disorder Associated with Trisomy 21. Neonatal Network 26:1, pages 7-19.
Crossref
Crossref
Angela E. Thomas. 2007. Fetal and Neonatal Pathology. Fetal and Neonatal Pathology
184
203
.
O. Golubnitschaja & M. Fountoulakis. 2007. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
345
358
.
David K.H. Webb. 2006. Pediatric Hematology. Pediatric Hematology
405
422
.
Natalia Dixon, Priya S. Kishnani & Sherri Zimmerman. (2006) Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 142C:3, pages 149-157.
Crossref
Crossref
Jennifer J.D. Morrissette, Gregory E. Halligan, Hope H. Punnett, Ann Shoemaker McKenzie, Felicula Guerrero & J.P. de Chadarévian. (2006) Down syndrome with low hypodiploidy in precursor B-cell acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics 169:1, pages 58-61.
Crossref
Crossref
Gita V. MasseyAlvin ZipurskyMyron N. ChangJohn J. DoyleSuhail NasimJeffrey W. TaubYaddanapudi RavindranathGary DahlHoward J. Weinstein. (2006) A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 107:12, pages 4606-4613.
Crossref
Crossref
Isis Quezado Magalhães, Alessandra Splendore, Mariana Emerenciano, Alexandre Figueiredo, Íris Ferrari & Maria S. Pombo-de-Oliveira. (2006) GATA1 mutations in acute leukemia in children with Down syndrome. Cancer Genetics and Cytogenetics 166:2, pages 112-116.
Crossref
Crossref
Anupama Rao, Robert K. Hills, Charles Stiller, Brenda E. Gibson, Siebold S.N. Graaf, Ian M. Hann, Aengus O'Marcaigh, Keith Wheatley & David K.H. Webb. (2006) Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. British Journal of Haematology 132:5, pages 576-583.
Crossref
Crossref
Robert B. Lorsbach & James R. Downing. 2010. Childhood Leukemias. Childhood Leukemias
298
338
.
Fred G. Behm. 2010. Childhood Leukemias. Childhood Leukemias
150
209
.
S. Diekamp, U. Creutzig, D. Reinhardt & M. Baumann-Köhler. (2006) Transitorisch myeloproliferatives Syndrom bei Neugeborenen mit Down-SyndromTransient myeloproliferative syndrome in neonates with Down syndrome. Monatsschrift Kinderheilkunde 154:2, pages 162-168.
Crossref
Crossref
Hideo Harigae. (2006) GATA Transcription Factors and Hematological Diseases. The Tohoku Journal of Experimental Medicine 210:1, pages 1-9.
Crossref
Crossref
Rika Kanezaki, Tsutomu Toki, Gang Xu, Ramswamy Narayanan & Etsuro Ito. (2006) Cloning and Characterization of the Novel Chimeric Gene p53/FXR2 in the Acute Megakaryoblastic Leukemia Cell Line CMK11-5. The Tohoku Journal of Experimental Medicine 209:3, pages 169-180.
Crossref
Crossref
K.F. Wong, S.C. Lam & Jennifer N.S. Leung. (2006) Isochromosome 7q in Down syndrome. Cancer Genetics and Cytogenetics 164:2, pages 152-154.
Crossref
Crossref
Olatoyosi M. Odenike, Laura C. Michaelis & Wendy Stock. 2006. Oncology. Oncology
1182
1209
.
L.S. Arya. (2005) Acute Lymphoblastic Leukemia: Current Treatment. Apollo Medicine 2:4, pages 319-323.
Crossref
Crossref
Andrew Jea, Edward R. Smith, Richard Robertson & R. Michael Scott. (2005) Moyamoya Syndrome Associated With Down Syndrome: Outcome After Surgical Revascularization. Pediatrics 116:5, pages e694-e701.
Crossref
Crossref
David K. H. Webb. (2005) Optimizing therapy for myeloid disorders of Down syndrome. British Journal of Haematology 131:1, pages 3-7.
Crossref
Crossref
J. Lawrence NaimanThomas D. Lamkin & Alan S. Gamis. 2009. Neonatal Hematology. Neonatal Hematology
385
405
.
Karen Blyth, Ewan R. Cameron & James C. Neil. (2005) The runx genes: gain or loss of function in cancer. Nature Reviews Cancer 5:5, pages 376-387.
Crossref
Crossref
Claudio Sandoval, Adam Davis & Somasundaram Jayabose. (2005) Eyelid Mass as the Presenting Finding in a Child With Down Syndrome and Acute Megakaryoblastic Leukemia. Pediatrics 115:3, pages 810-811.
Crossref
Crossref
Bernward Zeller, Goran Gustafsson, Erik Forestier, Jonas Abrahamsson, Niels Clausen, Jesper Heldrup, Liisa Hovi, Gudmundur Jonmundsson, Sverre O. Lie, Anders Glomstein & Henrik Hasle. (2005) Acute leukaemia in children with Down syndrome: a population-based Nordic study. British Journal of Haematology 128:6, pages 797-804.
Crossref
Crossref
John F. Bithell. 2005. Encyclopedia of Biostatistics. Encyclopedia of Biostatistics.
Johann K. Hitzler & Alvin Zipursky. (2005) Origins of leukaemia in children with Down syndrome. Nature Reviews Cancer 5:1, pages 11-20.
Crossref
Crossref
Jie Hu, Sofia Shekhter-Levin, Peter H. Shaw, Carolyn Bay, Sally Kochmar & Urvashi Surti. (2005) A case of myelodysplastic syndrome with acquired monosomy 7 in a child with a constitutional t(1;19) and a mosaicism for trisomy 21. Cancer Genetics and Cytogenetics 156:1, pages 62-67.
Crossref
Crossref
Yaddanapudi Ravindranath. (2005) Down syndrome and leukemia: New insights into the epidemiology, pathogenesis, and treatment. Pediatric Blood & Cancer 44:1, pages 1-7.
Crossref
Crossref
Julie A. Ross, Logan G. Spector, Leslie L. Robison & Andrew F. Olshan. (2005) Epidemiology of leukemia in children with Down syndrome. Pediatric Blood & Cancer 44:1, pages 8-12.
Crossref
Crossref
Gita V. Massey. (2005) Transient leukemia in newborns with Down syndrome. Pediatric Blood & Cancer 44:1, pages 29-32.
Crossref
Crossref
G Kaspers & Y Ravindranath. 2004. Textbook of Malignant Haematology, Second Edition. Textbook of Malignant Haematology, Second Edition
617
632
.
Elena TenediniMaria Elena FagioliNicola VianelliPier Luigi TazzariFrancesca RicciEnrico TagliaficoPaolo RicciLuigi GugliottaGiovanni MartinelliSante TuraMichele BaccaraniSergio FerrariLucia Catani. (2004) Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. Blood 104:10, pages 3126-3135.
Crossref
Crossref
Kimberly F. Kerstann, Eleanor Feingold, Sallie B. Freeman, Lora J. H. Bean, Robert Pyatt, Stuart Tinker, Amy H. Jewel, George Capone & Stephanie L. Sherman. (2004) Linkage disequilibrium mapping in trisomic populations: Analytical approaches and an application to congenital heart defects in Down syndrome. Genetic Epidemiology 27:3, pages 240-251.
Crossref
Crossref
Benjamin A. Solky, F. Clarissa Yang, Xiaowei Xu & Paul Levins. (2004) Transient Myeloproliferative Disorder Causing a Vesiculopustular Eruption in a Phenotypically Normal Neonate. Pediatric Dermatology 21:5, pages 551-554.
Crossref
Crossref
Shai Izraeli. (2004) Leukaemia - a developmental perspective. British Journal of Haematology 126:1, pages 3-10.
Crossref
Crossref
Sabine Dormann, Marcus Kr�ger, Roland Hentschel, Regina Rasenack, Brigitte Strahm, Udo Kontny & Charlotte Niemeyer. (2004) Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome. European Journal of Pediatrics 163:7, pages 374-377.
Crossref
Crossref
Suzanne McElwaine, Claire Mulligan, Jürgen Groet, Monica Spinelli, Andrea Rinaldi, Gareth Denyer, Afua Mensah, Simona Cavani, Chiara Baldo, Franca Dagna-Bricarelli, Ian Hann, Giuseppe Basso, Finbarr E. Cotter & Dean Nizetic. (2004)
Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing
PRAME
as a specific discriminating marker
. British Journal of Haematology 125:6, pages 729-742.
Crossref
Crossref
Anwar Sheikha. (2004) Fatal Familial Infantile Myelofibrosis. Journal of Pediatric Hematology/Oncology 26:3, pages 164-168.
Crossref
Crossref
Sandeep GurbuxaniParesh VyasJohn D. Crispino. (2004) Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 103:2, pages 399-406.
Crossref
Crossref
J. Rajantie & M. A. Siimes. (2003) Long‐term prognosis of children with Down's syndrome and leukaemia: a 34‐year nation‐wide experience. Journal of Intellectual Disability Research 47:8, pages 617-621.
Crossref
Crossref
Jillian M Baker, Max J Coppes & Birgitte Roland. (2003) A case of down syndrome with acute lymphoblastic leukemia and isochromosome Xp. Cancer Genetics and Cytogenetics 147:1, pages 75-77.
Crossref
Crossref
Alan S. GamisWilliam G. WoodsTodd A. AlonzoAllen BuxtonBeverly LangeDorothy R. BarnardStuart GoldFranklin O. Smith. (2003) Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891. Journal of Clinical Oncology 21:18, pages 3415-3422.
Crossref
Crossref
Yaddanapudi Ravindranath. (2003) Down Syndrome and Acute Myeloid Leukemia: The Paradox of Increased Risk for Leukemia and Heightened Sensitivity to Chemotherapy. Journal of Clinical Oncology 21:18, pages 3385-3387.
Crossref
Crossref
Sherry Bayliff, Joseph M. Horvatinovich, Jerald Z. Gong & Philip M. Rosoff. (2003) Lack of Circulating Megakaryoblasts in Newborn Peripheral Blood: Development and Validation of a Sensitive Flow Cytometric Detection Method. Journal of Pediatric Hematology/Oncology 25:9, pages 721-725.
Crossref
Crossref
Lawrence C. Wolfe, Howard J. Weinstein & Judith A. Ferry. (2003) Case 19-2003. New England Journal of Medicine 348:25, pages 2557-2566.
Crossref
Crossref
Johann K. HitzlerJoseph CheungYue LiStephen W. SchererAlvin Zipursky. (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101:11, pages 4301-4304.
Crossref
Crossref
Mary Faye Colby-Graham & Christine Chordas. (2003) The childhood leukemias. Journal of Pediatric Nursing 18:2, pages 87-95.
Crossref
Crossref
Alvin Zipursky. (2003) Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21. British Journal of Haematology 120:6, pages 930-938.
Crossref
Crossref
Lev Shvidel, Dina Shaft, Batia Stark, Mordechai Shtalrid, Alain Berrebi & Peretz Resnitzky. (2003) Acute basophilic leukaemia: eight unsuspected new cases diagnosed by electron microscopy. British Journal of Haematology 120:5, pages 774-781.
Crossref
Crossref
George Martin, Fuki Hisama & Sherman WeissmanStania Jurenka, Margot Van Allen & Leslie Colvin. 2003. Chromosomal Instability and Aging. Chromosomal Instability and Aging.
Johann K Hitzler. (2002) GATA1 — A Player in Normal and Leukemic Megakaryopoiesis. Pediatric Research 52:6, pages 831-831.
Crossref
Crossref
Wade Kyono & Thomas D Coates. (2002) A practical approach to neutrophil disorders. Pediatric Clinics of North America 49:5, pages 929-971.
Crossref
Crossref
Dorine Bresters, Angelino C. W. Reus, Anjo J. P. Veerman, Elizabeth R. Van Wering, Anna Van Der Does-van den Berg & Gertjan J. L. Kaspers. (2002) Congenital leukaemia: the Dutch experience and review of the literature. British Journal of Haematology 117:3, pages 513-524.
Crossref
Crossref
Jeffrey W. Taub & Yaddanapudi Ravindranath. (2002) Down Syndrome and the Transient Myeloproliferative Disorder: Why Is It Transient?. Journal of Pediatric Hematology/Oncology 24:1, pages 6-8.
Crossref
Crossref
Alan S. Gamis & Joanne M. Hilden. (2002) Transient Myeloproliferative Disorder, a Disorder With Too Few Data and Many Unanswered Questions: Does It Contain an Important Piece of the Puzzle to Understanding Hematopoiesis and Acute Myelogenous Leukemia?. Journal of Pediatric Hematology/Oncology 24:1, pages 2-5.
Crossref
Crossref
Hart IsaacsJr.Jr.. 2002. Tumors of the Fetus and Infant. Tumors of the Fetus and Infant
161
180
.
Betty K. OetamaRodney F. TucayDavid L. Morgan. (2001) Pathologic Quiz Case: Nonimmune Hydrops in a Newborn. Archives of Pathology & Laboratory Medicine 125:12, pages 1609-1610.
Crossref
Crossref
Ramesh A. Shivdasani. (2009) Molecular and Transcriptional Regulation of Megakaryocyte Differentiation. STEM CELLS 19:5, pages 397-407.
Crossref
Crossref
Georgina W. Hall. (2001) Childhood myeloid leukaemias. Best Practice & Research Clinical Haematology 14:3, pages 573-591.
Crossref
Crossref
Marcia Van Riper & William I. Cohen. (2001) Caring for children with Down syndrome and their families. Journal of Pediatric Health Care 15:3, pages 123-131.
Crossref
Crossref
Jeffrey W. Taub. (2001) Relationship of Chromosome 21 and Acute Leukemia in Children With Down Syndrome. Journal of Pediatric Hematology/Oncology 23:3, pages 175-178.
Crossref
Crossref
William B. Slayton & Kurt R. Schibler. (2000) CONGENITAL BONE MARROW FAILURE SYNDROMES ASSOCIATED WITH PROTEAN DEVELOPMENTAL DEFECTS AND LEUKEMIA. Clinics in Perinatology 27:3, pages 543-558.
Crossref
Crossref
Sylvie Paulien, Maryvonne Busson-Le Coniat & Roland Berger. (2000) Acute megakaryocytic leukaemia with acquired polysomy 21 and translocation t(1;21). Annales de Génétique 43:2, pages 99-104.
Crossref
Crossref
David Malkin, Elizabeth J Brown & Alvin Zipursky. (2000) The Role of p53 in Megakaryocyte Differentiation and the Megakaryocytic Leukemias of Down Syndrome. Cancer Genetics and Cytogenetics 116:1, pages 1-5.
Crossref
Crossref
Dorothée Duflos-Delaplace, Jean-Luc Laı̈, Brigitte Nelken, Franck Genevieve, Anne-Sophie Defachelles & Marc Zandecki. (1999) Transient Leukemoid Disorder in a Newborn with Down Syndrome Followed 19 Months Later by an Acute Myeloid Leukemia. Cancer Genetics and Cytogenetics 113:2, pages 166-171.
Crossref
Crossref
Jane E. Sande, Robert J. Arceci & Beatrice C. Lampkin. (1999) Congenital and neonatal leukemia. Seminars in Perinatology 23:4, pages 274-285.
Crossref
Crossref
Margot I. van Allen, Julian Fung & Stania B. Jurenka. (1999) Health care concerns and guidelines for adults with Down syndrome. American Journal of Medical Genetics 89:2, pages 100-110.
Crossref
Crossref
C. Rizzari, R. Malberti, M. Dell'Orto, M. Milani, M. Jankovic, E. Ferrari & V. Conter. (1999) Transient myeloproliferative disorder associated with trisomy 21: Is a short course of chemotherapy indicated in patients with liver impairment and severe clinical problems?. Medical and Pediatric Oncology 32:6, pages 453-454.
Crossref
Crossref
Fred G. Behm. (1999) Diagnosis of Childhood Acute Myeloid Leukemia. Clinics in Laboratory Medicine 19:1, pages 187-238.
Crossref
Crossref
Zipursky Alvin, Elizabeth J. Brown, Christensen Hilary & Doyle John. (1999) Transient Myeloproliferative Disorder (Transient Leukemia) and Hematologic Manifestations of Down Syndrome. Clinics in Laboratory Medicine 19:1, pages 157-168.
Crossref
Crossref
Ivan P. G. Moskowitz, Paul S. Gaynon, Nasrollah T. Shahidi & Timothy P. Cripe. (1999) Low-Dose Cyclosporin A Therapy in Children With Refractory Immune Thrombocytopenic Purpura. Journal of Pediatric Hematology/Oncology 21:1, pages 77-79.
Crossref
Crossref
Sallie B. Freeman, Lisa F. Taft, Kenneth J. Dooley, Katherine Allran, Stephanie L. Sherman, Terry J. Hassold, Muin J. Khoury & Denise M. Saker. (1998) Population-based study of congenital heart defects in Down syndrome. American Journal of Medical Genetics 80:3, pages 213-217.
Crossref
Crossref
Jane H. Ives, Franca Dagna-Bricarelli, Giuseppe Basso, Stylianos E. Antonarakis, Roger Jee, Finbarr Cotter & Dean Nižetić. (1998) Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor(TIAM1) mRNA in bone marrow of down syndrome children during the acute phase of AML(M7). Genes, Chromosomes and Cancer 23:1, pages 61-66.
Crossref
Crossref
Daniel Satg�, Dani�le Sommelet, Aim� Geneix, Motoi Nishi, Paul Malet & Michel Vekemans. (1998) A tumor profile in Down syndrome. American Journal of Medical Genetics 78:3, pages 207-216.
Crossref
Crossref
Shinji Kounami, Noriyuki Aoyagi, Hiroshi Tsuno, Hiroyuki Suzuki, Masakazu Kobayashi & Michio Koike. (1998) Myelodysplastic Syndrome after Regression of Transient Abnormal Myelopoiesis in a Down Syndrome Infant. Cancer Genetics and Cytogenetics 104:2, pages 115-118.
Crossref
Crossref
David H. Ebb & Howard J. Weinstein. (1997) DIAGNOSIS AND TREATMENT OF CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA. Pediatric Clinics of North America 44:4, pages 847-862.
Crossref
Crossref
Jeffrey E. RubnitzWilliam M. Crist. (1997) Molecular Genetics of Childhood Cancer: Implications for Pathogenesis, Diagnosis, and Treatment. Pediatrics 100:1, pages 101-108.
Crossref
Crossref
Thierry Leblanc & Roland Berger. (2009) Molecular cytogenetics of childhood acute myelogenous leukaemias. European Journal of Haematology 59:1, pages 1-13.
Crossref
Crossref
Ofer Shpilberg, Janice S. Dorman, Avner Shahar & Lewis H. Kuller. (1997) Molecular epidemiology of hematological neoplasms—Present status and future directions. Leukemia Research 21:4, pages 265-284.
Crossref
Crossref
Lisa H. Lerner & Elizabeth M. Bailey. (1996) Case 18-1996. New England Journal of Medicine 334:24, pages 1591-1597.
Crossref
Crossref
D. LEVANON, Y. BERNSTEIN, V. NEGREANU, M.C. GHOZI, I. BAR-AM, R. ALOYA, D. GOLDENBERG, J. LOTEM & Y. GRONER. (1996) A Large Variety of Alternatively Spliced and Differentially Expressed mRNAs Are Encoded by the Human Acute Myeloid Leukemia Gene AML1. DNA and Cell Biology 15:3, pages 175-185.
Crossref
Crossref
Daniel Satge & Herman Van Den Berghe. (1996) Aspects of the neoplasms observed in patients with constitutional autosomal trisomy. Cancer Genetics and Cytogenetics 87:1, pages 63-70.
Crossref
Crossref
Gil Tchernia, Francoise Lejeune, Jean-Francoise Boccara, Marie-Francoise Denavit, Jean-Paul Dommergues & Francoise Bernaudin. (1996) Erythroblastic and/or Megakaryoblastic Leukemia in Down Syndrome. Journal of Pediatric Hematology/Oncology 18:1, pages 59-62.
Crossref
Crossref
&NA;. (1996) The Treatment of Children with Acute Megakaryoblastic Leukemia Who Have Down Syndrome. Journal of Pediatric Hematology/Oncology 18:1, pages 10-12.
Crossref
Crossref
Mahvash Navazesh, Roseann Mulligan & Stephen Sobel. (2008) Toxic Shock and Down Syndromes in a dental patient: A case report and review of the literature. Special Care in Dentistry 14:6, pages 246-251.
Crossref
Crossref
Alan E. Donnenfeld, Steven C. Scott, Marie Henselder‐Kimmel & Carlton D. Dampier. (2005) Prenatally diagnosed non‐immune hydrops caused by congenital transient leukaemia. Prenatal Diagnosis 14:8, pages 721-724.
Crossref
Crossref
Sofia Shekhter-Levin, Joseph Mirro, Lila Penchansky, Maureen E. Sherer, Niel Wald & Susanne M. Gollin. (1994) Acute myeloblastic leukemia with a pericentric inversion of chromosome 6 in a child with down syndrome. Cancer Genetics and Cytogenetics 73:2, pages 157-160.
Crossref
Crossref
Lilian Zihni. (1994) Down's syndrome, interferon sensitivity and the development of leukaemia. Leukemia Research 18:1, pages 1-6.
Crossref
Crossref
Alvin Zipursky & John Doyle. (1993) Leukemia in newborn infants with down syndrome. Leukemia Research 17:2, pages 195.
Crossref
Crossref
. (2008) BIBLIOGRAPHY OF DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY: SELECTED BOOKS AND ARTICLES RECEIVED IN 1992. Developmental Medicine & Child Neurology 35:s67-69, pages 1-129.
Crossref
Crossref